BVI Medical Secures $1 Billion Strategic Investment from TPG to Accelerate Global Expansion and Challenge Alcon, Johnson & Johnson Dominance

Mar 11, 2025 11:00 CST Updated 11:00

BVI Medical

Ophthalmic Instrument R&D Manufacturer

TPG

Global Private Equity Investment Firms

BVI Medical Announces $1 Billion Strategic Financing with Alternative Asset Management Company TPG. This financing fully replaces...BVI Medical's existing debt, along with the introduction of new equity from TPG and new investors, has strengthened the company's financial position, injecting strong momentum into its accelerated product innovation and global expansion.

This financing will accelerateBVI Medical Global Business Expansion. RecentlyBVI MedicalTo meet the global demand growth by expanding the European intraocular lens (IOL) production base, launching new product lines such as the SERENITY and SERENITY Toric premium monofocal intraocular lenses, and strengthening market position through strategic acquisitions.

Investor Evaluation

"TPG is honored to continue its partnership with BVI Medical, jointly expanding its influence in the global ophthalmic medical field."

---Kendall Garrison TPG Partner

"BVI Continues to Strengthen Its Market Position While Elevating Global Patient Care, This Investment Will Provide Stronger Momentum for Innovation and Expansion. We Look Forward to Witnessing BVI's Continued Success."

---John Schilling Co-Managing Partner of TPG Capital

Executive Evaluation

"This financing marks a significant turning point in BVI's development. We will enhance our comprehensive capabilities to meet the growing market demand for advanced ophthalmic solutions. By promoting the widespread adoption of breakthrough technologies among surgeons worldwide, we are reshaping the future of ophthalmic surgery and transforming the competitive landscape of the industry."

---Shervin Korangy President and CEO of BVI Medical

BVI Medical is a rapidly growing company focused on the ophthalmology field. It has been very active in the capital market in the past two years. In recent years,BVI Medical Through M&AContinuously improving their product lines and sales channels to make their ophthalmic solutions more competitive. BVI Medical was among the top ten ophthalmic M&A deals in both 2023 and 2024:

2023BVI Medical Acquires Medical Mix, a Professional Medical Device Company Focused on Ophthalmic Surgery in Spain and Portugal, Achieving Strategic Progress in Its Growth Trajectory.Medical Mix as of since 2008BVI Medical Intraocular Lens (IOL), Long-term Distributor of Consumables Since 2012 and Equipment Since 2019, in PromotionBVI Medical products have played a key role.
In 2024, the acquisition of the ophthalmology division of Surgical Specialties Corporation was completed. This acquisition added high precisionMicroscissorsAnd suturing materials and other disposable surgical devices have injected new vitality into BVI Medical's product line. As a global leading supplier of ophthalmic surgical equipment, BVI Medical has strengthened its dominant position in the ophthalmic surgical consumables market through this strategic move, providing doctors with higher-quality surgical tools.

WithTPG Invests,Will enableBVI Medical is "bolder" in terms of M&A and can completeLarger M&A, thereby enablingBVI Medical Becomes More Competitive in the Ophthalmology Field, BreakingLeading enterprises (such as Alcon, Johnson & Johnson, and Zeiss) dominate the market.. Just likeAs the president of BVI Medical saidChange the competitive landscape of the industry.

BVI Medical Product Line

The BVI Medical product line can be subdivided into four product lines: Digestive Products, Equipment, Crystals, and Gases & Liquids.。

Digestive Products

Equipment

Crystal

Gas & Liquid

BVI Medical

BVI Medical is a diversified global ophthalmic medical device company dedicated to advancing ophthalmic surgery and improving patient vision through high-quality solutions and innovative technologies. With ninety years of deep industry expertise,BVI Medical collaborates with ophthalmologists worldwide to bring vision to millions of patients.